PolyCore Therapeutics
Seed Round in 2022
PolyCore Therapeutics is a biotechnology company focused on developing innovative treatments for central nervous system (CNS) disorders. The company's research specifically targets dyskinesia and cognitive impairment associated with conditions such as Parkinson's disease. PolyCore is committed to creating new, affordable therapies aimed at managing the side effects of existing treatments, which can enhance patient mobility and quality of life. By prioritizing the development of breakthrough therapeutics, PolyCore Therapeutics seeks to address significant healthcare challenges while also aiming to reduce overall healthcare costs for patients suffering from neurological diseases.
AmorSui
Seed Round in 2022
AmorSui is a modern protective apparel company that specializes in the design and innovation of medical gowns and lab jackets for healthcare professionals. Founded in 2020 by Beau Wangtrakuldee, PhD, the company emerged from a personal experience that highlighted the need for better protective gear. AmorSui's products are characterized by their antimicrobial properties, static resistance, and protection against bodily fluids, while being reusable and recyclable. Committed to sustainability, the company ensures that all its apparel is made and sourced entirely in the USA. In addition to its protective garments, AmorSui offers a management platform that utilizes data analytics to monitor the lifecycle of its products, enabling healthcare facilities to reduce waste and costs while ensuring employee safety.
Nia Therapeutics
Venture Round in 2021
Nia Therapeutics, Inc. is a company focused on developing precision neurostimulation therapies aimed at treating memory impairment, particularly in patients with traumatic brain injury. Founded in 2016, Nia Therapeutics is based in Radnor, Pennsylvania. The company's innovative approach involves utilizing neurostimulation devices that interpret complex brain activity related to memory function. By providing personalized therapy through deep-brain stimulation, Nia Therapeutics aims to enhance memory restoration and improve cognitive outcomes for affected individuals.
Astarte Medical
Series A in 2021
Astarte Medical Partners, Inc. is a clinical intelligence company focused on enhancing health outcomes for children with medical complexities, particularly in neonatal intensive care units (NICUs). Incorporated in 2016 and based in Yardley, Pennsylvania, the company develops software that delivers a comprehensive view of clinical data in real time, specifically aimed at assessing the gut health of preterm infants. This platform allows clinical care teams to standardize and optimize feeding practices and protocol-driven care, thereby facilitating informed decision-making. Astarte Medical's suite of digital tools and predictive analytics supports nutrition and feeding practices, enabling healthcare providers to monitor growth and track clinical outcomes effectively. By improving care practices in acute settings, the company strives to make a significant impact on the long-term health of vulnerable pediatric populations.
RecoveryLink
Pre Seed Round in 2021
RecoveryLink is a developer of a comprehensive digital recovery support platform aimed at enhancing behavioral health outcomes. The company offers a range of services including electronic recovery records, asynchronous digital training, one-on-one telerecovery peer services, and live video group-based recovery supports. By providing these tools, RecoveryLink enables clients to access effective recovery support solutions that promote organizational efficiency and improve the overall recovery process for individuals seeking assistance. The platform's design focuses on facilitating better engagement and outcomes in the behavioral health sector through innovative technology and supportive resources.
Vesteck is a clinical stage medical device company dedicated to developing innovative solutions for the treatment of aortic aneurysms and related conditions. The company specializes in proprietary technology aimed at the aortic repair, structural heart, and gastrointestinal markets. Its flagship product, the Suture-Tight™ nitinol suture delivery catheter, introduces a novel approach to endovascular aortic repair. This technology addresses critical challenges faced by physicians and patients by securely suturing endovascular grafts to the aorta during initial implants or repairs. Additionally, Vesteck's advancements aim to minimize issues such as graft migration and leaks, which can lead to complex and costly interventions. Through its focus on enhancing patient care and improving outcomes, Vesteck is positioned to make a significant impact in the medical device industry.
Pression
Pre Seed Round in 2020
Pression is a developer of a patented, non-invasive smart compression platform known as the Wave. This system is designed to enhance circulation throughout the body and improve cardiac function, with a primary focus on supporting heart failure patients. By mobilizing excess retained fluids, which is a leading cause of hospitalization in the United States, the Wave aims to increase oxygen delivery to vital organs and enhance overall quality of life. The platform leverages proven scientific principles while addressing the limitations of previous systems, ultimately promoting greater independence and improved exercise tolerance for patients suffering from circulatory conditions.
Repisodic
Debt Financing in 2020
Repisodic, Inc. is a health technology company based in Philadelphia, Pennsylvania, that focuses on streamlining the transition of care for patients moving from hospital settings to post-acute care facilities such as nursing homes and rehabilitation centers. Founded in 2017, the company develops a digital healthcare ecosystem that aids hospitals in managing the discharge process effectively. Its platform utilizes proprietary data and automation to match patients with suitable post-hospital care options, taking into account factors like insurance coverage, clinical capabilities, and provider availability. Repisodic's solutions include the repisodic Choice, which creates dynamic preferred provider networks tailored to patients' needs, and repisodic Link, designed to facilitate referrals and connect post-acute care providers with patients during their care decision-making process. By enhancing the discharge experience, Repisodic aims to improve outcomes for patients, families, and healthcare providers alike.
Bainbridge Health
Debt Financing in 2020
Bainbridge Health, Inc. is a Philadelphia-based company founded in 2016 that specializes in developing a clinical intelligence and data analytics platform aimed at enhancing medication safety in hospital settings. The company's offerings include a vendor-agnostic medication safety platform that streamlines data management, reducing the reliance on manual data clerking and ad-hoc reporting. Their solutions, designed for medication safety leaders and hospital safety professionals, include an infusion pump management software known as InfusionWare, which centralizes infusion data to improve patient safety and effectively manage pump information. By mitigating medication errors, Bainbridge Health's platform helps healthcare providers reduce avoidable costs and improve overall patient care.
Chromatan
Debt Financing in 2020
ChromaTan Inc. is a biotechnology company based in Lower Gwynedd, Pennsylvania, that specializes in the development of continuous countercurrent tangential chromatography (CCTC) technology for the purification of monoclonal antibodies and proteins. Founded in 2007, ChromaTan addresses a significant bottleneck in therapeutic protein production by providing an innovative, column-free, continuous, and single-use purification solution. This technology replaces traditional large-scale column chromatography processes, offering a cost-effective and scalable alternative for biotech and contract manufacturing companies. ChromaTan's CCTC platform has undergone extensive beta testing with major biotech firms, demonstrating a substantial increase in throughput while maintaining or improving product quality.
Mediscore
Debt Financing in 2020
Mediscore Health, founded in 2017, is based in Philadelphia, Pennsylvania with an additional location in Santa Monica, California. The company specializes in providing data-driven insights for healthcare solutions, focusing on chronic care management and risk adjustment for Medicare Advantage payers and Accountable Care Organizations (ACOs). Mediscore Health offers services such as physician-driven chart review and analytics, predictive diagnostics, and point-of-care disease management. Their technology-enabled approach is designed to help providers diagnose, document, and manage chronically ill patients effectively at the primary care level.
OsciFlex
Debt Financing in 2020
OsciFlex LLC, established in 2017 and headquartered in Philadelphia, Pennsylvania, specializes in developing a medical device aimed at preventing blood clots from forming at valves. The company's innovative product mimics nature's process to provide more effective compression therapy, reducing the risk of Venous thromboembolism (VTE) in patients and potentially decreasing reliance on costly and risky anti-coagulation pharmaceuticals.
Excision BioTherapeutics
Debt Financing in 2020
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company is dedicated to the development and commercialization of gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company's mission is to advance these therapeutics into safe and effective treatments, significantly improving the lives of individuals affected by viral infections globally.
iOrtho+
Debt Financing in 2020
iOrtho+ is a medical software company specializing in orthopedic care through its innovative product, the Mobil-Aider. This web-based application is designed to quantify joint mobility and allows clinicians to assess at least 14 motions across five different joints. The Mobil-Aider features a vast array of resources, offering 450 tests, 1,300 references, and 100 mobilization techniques. It serves as a comprehensive reference tool for orthopedic professionals, providing concise descriptions, images, videos, and statistical data, all of which enhance the clinician's ability to improve treatment outcomes and techniques.
Aevumed
Debt Financing in 2020
Aevumed is a privately-owned company focused on developing innovative medical devices aimed at improving treatment outcomes for rotator cuff tears. The company's flagship device enhances healing by providing superior pull-out strength and suture retention, which facilitates better integration between tendon and bone. This technology addresses the critical issue of retear rates in rotator cuff surgeries, offering patients both mechanical support and biological enhancement. Aevumed is dedicated to improving quality of life through its continuous commitment to innovation and quality, as well as its strategic expansion into new territories.
Cassian Solutions
Seed Round in 2020
Cassian Solutions, Inc. is a company based in Phoenixville, Pennsylvania, that specializes in developing innovative medication management solutions. Founded in 2018, it designs and manufactures a unique phone case medication dispenser alongside a comprehensive application that enhances patient adherence to prescribed treatments. The app features tools for outcome collection, biometric verification, medication reminders, adherence verification, environmental sensing, treatment analysis, real-time communication, and medication distribution. Cassian Solutions serves a diverse clientele, including pharmacies, clinical trial companies, drug manufacturers, and insurers. By addressing critical gaps in patient monitoring and data reporting, the company aims to improve health outcomes and streamline the pharmaceutical value chain, ultimately enhancing the medication experience for patients and healthcare providers alike.
AAPlasma is developing a cold plasma-based system that is based on previously-successful technology capable of achieving in-between-patient decontamination of PPE items to allow for rapid reuse.
DRSLINQ is developing a mobile EKG device that is coupled to an interactive application powered by a natural language processing integrated with a machine learning platform to appropriately triage chest pain patients to the ER.
Dynamis Skin Science
Grant in 2020
Dynamis Skin Science, Inc. is a Jenkintown, Pennsylvania-based company focused on developing and supplying innovative skin care products featuring its proprietary ingredient, Supplamine. Founded in 2006, the company offers a diverse range of products aimed at enhancing skin health and addressing anti-aging concerns. Its product portfolio includes treatments for the face, eyes, and hands, as well as moisturizers and cleansers designed to improve skin appearance and health. Dynamis Skin Science markets its offerings through authorized distributors, online platforms, and licensed skin-care professionals, ensuring accessibility to a broad customer base. The company operates as a subsidiary of Dynamis Therapeutics, Inc.
Open Medical Innovation
Grant in 2020
Open Medical Innovation is an organization founded by leaders from Archimedic, NextFab, and the University of Pennsylvania. We launched this organization with a focus on addressing the shortage of Personal Protective Equipment (PPE) during the COVID-19 outbreak. We intend to use this website to share information, collect feedback, and fulfill the unmet needs of patients and providers.
Cogwear is a brain technology company focused on assisting individuals who experience anxiety and depression. The company is developing an advanced wearable device that transcends existing products by integrating cognitive and emotional insights with physical measurements. This innovation aims to enhance human health, safety, and performance. Cogwear utilizes AI-powered algorithms to provide users with real-time access to clinical-grade cognitive and emotional data in various environments. Its wearables are equipped with mobile electroencephalogram (EEG) sensors and machine learning technology, allowing for the accurate measurement and interpretation of brainwave activity. The proprietary dry EEG sensors are designed for comfort and precision, enabling users to track their brain activity through a secure application and shareable dashboard.
Pression is a developer of a patented, non-invasive smart compression platform known as the Wave. This system is designed to enhance circulation throughout the body and improve cardiac function, with a primary focus on supporting heart failure patients. By mobilizing excess retained fluids, which is a leading cause of hospitalization in the United States, the Wave aims to increase oxygen delivery to vital organs and enhance overall quality of life. The platform leverages proven scientific principles while addressing the limitations of previous systems, ultimately promoting greater independence and improved exercise tolerance for patients suffering from circulatory conditions.
Optical Inventory Solutions
Grant in 2020
Optical Inventory Solutions is the developer of ViewVax, a leading automated vaccine inventory management system. ViewVax seamlessly integrates with existing medical refrigerators, allowing hospitals, clinics, and doctors' offices to optimize their vaccine storage while utilizing advanced hardware and software. The system features a web-connected camera that accurately counts on-hand vaccine inventory, facilitating automatic reordering and reducing excess stock levels. This innovative solution not only simplifies the management of vaccines but also enhances operational efficiency by providing precise data recognition and maintaining proper inventory levels in cold storage environments.
SFA Therapeutics
Grant in 2020
SFA Therapeutics, Inc. is a development-stage biopharmaceutical company based in Jenkintown, Pennsylvania, that specializes in the development of microbiome-derived metabolites as therapeutic agents for chronic inflammatory diseases and cancer. The company focuses on harnessing compounds discovered in the human microbiome to create innovative treatments aimed at addressing conditions such as cancer, liver diseases, and autoimmune disorders. Through its novel platform, SFA Therapeutics seeks to advance the understanding and application of microbiome science in the field of medicine, providing new options for medical professionals in the treatment of these challenging health issues.
Narbis is a developer and manufacturer of innovative wearable technologies aimed at enhancing mental wellness through neurofeedback. The company's flagship product, Narbis Smartglasses, enables users, particularly those with ADHD, to improve focus and concentration without the use of medication. This technology, originally developed in collaboration with NASA, incorporates a patented conditioning mechanism that helps users assess their performance while engaging in tasks such as reading or completing homework. Additionally, Narbis offers a product called Narbis illume, which employs colored light, sound, and tactile transducers to facilitate Audio Visual Entrainment (AVE). This combination promotes relaxation, reduces anxiety, enhances focus, and supports meditation. Both products are available directly to consumers through the Narbis website.
Narbis is a developer and manufacturer of innovative wearable technologies aimed at enhancing mental wellness through neurofeedback. The company's flagship product, Narbis Smartglasses, enables users, particularly those with ADHD, to improve focus and concentration without the use of medication. This technology, originally developed in collaboration with NASA, incorporates a patented conditioning mechanism that helps users assess their performance while engaging in tasks such as reading or completing homework. Additionally, Narbis offers a product called Narbis illume, which employs colored light, sound, and tactile transducers to facilitate Audio Visual Entrainment (AVE). This combination promotes relaxation, reduces anxiety, enhances focus, and supports meditation. Both products are available directly to consumers through the Narbis website.
Hava Health
Pre Seed Round in 2019
Hava Health, Inc. is a biotechnology company based in the United States that specializes in developing innovative solutions for nicotine addiction. The company manufactures a smoking cessation device, which includes a connected vape pen that integrates with a smartphone application called Hale. This digital drug therapy device aims to support individuals in their efforts to quit smoking by providing a modern approach to nicotine de-addiction. Through its technology, Hava Health seeks to enhance the effectiveness of smoking cessation efforts and improve health outcomes for users.
Navrogen
Convertible Note in 2019
Navrogen is a biopharmaceutical company based in Philadelphia, Pennsylvania, incorporated in 2017. The company specializes in developing technology platforms aimed at enhancing the immune system's ability to fight cancer. Navrogen focuses on identifying and addressing factors produced or induced by tumor cells that suppress the humoral immune response against cancer cells. By targeting these immunosuppressive effects, Navrogen aims to improve the efficacy of antibody-based drugs and develop more effective cancer treatments.
Astarte Medical
Series A in 2019
Astarte Medical Partners, Inc. is a clinical intelligence company focused on enhancing health outcomes for children with medical complexities, particularly in neonatal intensive care units (NICUs). Incorporated in 2016 and based in Yardley, Pennsylvania, the company develops software that delivers a comprehensive view of clinical data in real time, specifically aimed at assessing the gut health of preterm infants. This platform allows clinical care teams to standardize and optimize feeding practices and protocol-driven care, thereby facilitating informed decision-making. Astarte Medical's suite of digital tools and predictive analytics supports nutrition and feeding practices, enabling healthcare providers to monitor growth and track clinical outcomes effectively. By improving care practices in acute settings, the company strives to make a significant impact on the long-term health of vulnerable pediatric populations.
RoundTrip
Series A in 2019
RoundTrip, Inc. operates a digital marketplace that facilitates non-emergency medical transportation by connecting patients with a network of ride providers. Founded in 2014 and based in Philadelphia, Pennsylvania, the company offers a user-friendly software platform that allows healthcare organizations and transportation companies to schedule, dispatch, and monitor patient rides. RoundTrip serves hospitals and health plans in ten states, aiming to improve care coordination and reduce patient no-shows. The platform provides access to various transportation options, including medical cars, wheelchair vans, and stretcher vehicles. RoundTrip has established strategic partnerships with notable healthcare organizations, enhancing its service offerings. The team behind RoundTrip consists of professionals with experience as paramedics and in healthcare management, which informs their approach to addressing the challenges in medical transportation.
Tridiuum, Inc. is a digital health company that specializes in providing software solutions for behavioral health providers, patients, and health systems. Founded in 1997 and based in Philadelphia, the company operates a cloud-based platform known as Tridiuum1, which focuses on behavioral health outcomes management. This platform enables the monitoring of patients' symptoms and treatment progress, thereby enhancing patient experiences and outcomes in healthcare settings. Tridiuum's technology integrates digital health assessments with analytics to identify behavioral health issues, assign risk scores, and deliver real-time alerts at the point of care. Additionally, it supports features like video-based virtual visits, equipping clinicians to effectively evaluate, predict, and manage the care of patients facing various conditions. The company is driven by a team of experts in behavioral medicine and digital health technologies, with a strong clinical foundation rooted in research and evidence-based practices.
MBF Therapeutics
Seed Round in 2018
MBF Therapeutics, Inc. is a veterinary oncology company based in Ambler, Pennsylvania, focused on developing and commercializing innovative therapies for cancer treatment in dogs and cats. The company specializes in targeted immunotherapies and small molecule drugs that effectively disrupt tumor cell metabolism while preserving healthy cells and organs. Its product portfolio includes MBFT-101, a combination therapy for sarcomas and lymphoma, featuring a proprietary polyamine transport inhibitor and a potent inhibitor of ornithine decarboxylase, as well as MBFT-102, an immunotherapy based on the tumor suppressor/cytokine mda-7/IL24, which has shown promise in human cancers. Additionally, MBF Therapeutics employs a proprietary DNA vaccine platform and delivery system to develop immunotherapeutic vaccines aimed at enhancing protective immunity against infectious diseases in companion animals and livestock. The company maintains a strategic partnership with the Lankenau Institute for Medical Research to further advance its research and development initiatives.
Bakround
Seed Round in 2018
Bakround, Inc. is a Philadelphia-based company founded in 2014 that specializes in healthcare recruiting through an advanced AI-driven platform. The company offers a range of online services, including employment resources, job listings, resume matching, and employment verification. Bakround's platform is designed to enhance the recruiting process by utilizing artificial intelligence to improve precision in matching candidates with job requirements. This innovative approach allows recruiters to effectively assess and rate applicants based on how well their qualifications align with specific roles, streamlining the hiring process for both employers and job seekers. Additionally, Bakround provides tools for employees and applicants to store and share their employment assets, facilitating a more efficient recruitment experience.
RoundTrip
Seed Round in 2018
RoundTrip, Inc. operates a digital marketplace that facilitates non-emergency medical transportation by connecting patients with a network of ride providers. Founded in 2014 and based in Philadelphia, Pennsylvania, the company offers a user-friendly software platform that allows healthcare organizations and transportation companies to schedule, dispatch, and monitor patient rides. RoundTrip serves hospitals and health plans in ten states, aiming to improve care coordination and reduce patient no-shows. The platform provides access to various transportation options, including medical cars, wheelchair vans, and stretcher vehicles. RoundTrip has established strategic partnerships with notable healthcare organizations, enhancing its service offerings. The team behind RoundTrip consists of professionals with experience as paramedics and in healthcare management, which informs their approach to addressing the challenges in medical transportation.
VitalTrax
Seed Round in 2017
VitalTrax connects patients with clinical trials with its cloud-based clinical trial network. VitalTrax offers Wing, a solution that simplifies clinical trials enrollment. Wing is a clinical trial network that provides innovative ways for people to easily seek optional treatments for themselves or people that they love and play an important role in helping develop new ways to fight diseases.
Keriton
Seed Round in 2017
Keriton LLC is a company that specializes in providing a pumped breast milk management system tailored for neonatal intensive care units (NICUs). Its platform facilitates the tracking of milk-bottle inventory, feeding orders, and recipes through mobile devices. The system enhances patient safety by implementing first-in-first-out (FIFO) bottle flow management, notifying users of expiry dates, and issuing alerts for potential misfeeds. Additionally, Keriton offers a media-sharing platform that allows nurses to share photos and videos of NICU babies with their mothers, fostering communication and engagement. The company also provides real-time insights into the milk production patterns of lactating mothers. Incorporated in 2016 and based in Philadelphia, Pennsylvania, Keriton's software-as-a-service (SaaS) solution has been deployed in various large healthcare systems, managing over 1.5 million feeds and significantly reducing nursing errors while improving overall patient outcomes.
Binto LLC, founded in 2015 and headquartered in Philadelphia, Pennsylvania, specializes in designing and manufacturing health supplements and organic products aimed at women's reproductive health. The company offers a range of fertility supplements, women's health supplements, and organic period products, including gluten-free, vegan-friendly options that are free from preservatives and fillers. Binto creates personalized supplement kits tailored for women of all ages, utilizing only natural and effective ingredients. Its products are backed by high-quality research and are offered at affordable prices. Additionally, Binto provides access to licensed healthcare professionals, ensuring that women worldwide have the resources they need to manage their health effectively from menstruation through menopause.
ROAR for Good LLC is a woman-led technology company based in Philadelphia, Pennsylvania, focused on enhancing personal safety through innovative solutions. Established in 2014, the company designs self-defense jewelry and mobile technology aimed at reducing assault incidents, particularly against women. Its flagship product, the AlwaysOn employee safety platform, caters specifically to the hotel industry, ensuring compliance with safety standards while promoting employee well-being. The platform operates on mission-critical networks, providing reliable protection even without Wi-Fi or power. Additionally, ROAR for Good offers self-defense education to empower women and improve workplace safety across various sectors, including hospitality and healthcare.
Shock Analytics
Seed Round in 2016
Shock Analytics LLC is an early-stage biomedical device company based in Philadelphia, Pennsylvania, established in 2016. The firm specializes in the design and manufacture of noninvasive diagnostic devices aimed at improving the management of acute and chronic illnesses. Its primary focus is on developing technology that estimates Systemic Vascular Resistance (SVR), a critical indicator for conditions such as congestive heart failure and sepsis. By utilizing hemodynamic information, Shock Analytics' devices enable healthcare professionals to effectively treat and monitor patients suffering from these serious medical conditions.
SonoSolve
Seed Round in 2016
SonoSolve is a revolutionary new device that aims to eliminate catheter-associated complications, using non-invasive sound waves to clear obstructions and biofilms within catheters. SonoSolve is the BUZZ in Blockages!
GSI Health
Seed Round in 2016
GSI Health, LLC is a health information technology company that specializes in developing a population health management platform. Founded in 2003 and based in Philadelphia, Pennsylvania, with an additional office in New York, GSI Health offers cloud-based software solutions aimed at enhancing care coordination, improving transitions in care, and reducing avoidable hospital readmissions. The platform supports hospitals, health systems, managed care organizations, health plans, Medicaid programs, and community-based organizations by facilitating better communication and information sharing among all healthcare providers involved in a patient's care. It features built-in health information exchange capabilities that allow for effective analytics and reporting, ultimately providing a personalized healthcare experience for patients. As of late 2019, GSI Health operates as a subsidiary of Medecision, Inc.
Instadiagnostics
Seed Round in 2016
Instadiagnostics Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing a point-of-care (POC) diagnostic platform. Founded in 2015, the platform aims to bring centralized laboratory testing directly to patients at their bedside, facilitating early diagnosis and treatment monitoring. This innovative approach allows patients to receive timely medical care in various settings, including primary care centers, community clinics, and emergency departments, without the need for additional trips to have blood drawn or enduring long wait times for results. By streamlining the diagnostic process, Instadiagnostics seeks to enhance patient care and satisfaction, reduce the frequency of medical visits, and ultimately lower overall healthcare costs.
Polaris Health Directions
Seed Round in 2016
POLARIS HEALTH DIRECTIONS develops and markets behavioral health outcomes assessment and management systems to help deliver better health outcomes at a reduced cost. Polaris systems are designed for use by health care providers, managed care organizations, government agencies and pharmaceutical companies, and focus on addressing the impact mental health conditions have on physical health and an individual’s welfare. These solutions help Polaris's clients identify, monitor and address psychosocial and behavioral health conditions to curb long-term health effects and costs.
CyberCrunch
Seed Round in 2016
CyberCrunch is a Pennsylvania-based company established in 2010, specializing in secure electronics recycling and data destruction services nationwide. They provide comprehensive solutions for various electronic waste items such as computers, servers, monitors, and consumer electronics, along with non-electronics recycling like batteries and light bulbs. Their core service involves permanent data destruction through hard drive shredding, degaussing, and multi-pass wiping, ensuring compliance with relevant regulations. Additionally, they offer IT consulting services for asset management and disposition. CyberCrunch serves diverse sectors including healthcare, finance, education, and small businesses.
PolyCore Therapeutics
Seed Round in 2016
PolyCore Therapeutics is a biotechnology company focused on developing innovative treatments for central nervous system (CNS) disorders. The company's research specifically targets dyskinesia and cognitive impairment associated with conditions such as Parkinson's disease. PolyCore is committed to creating new, affordable therapies aimed at managing the side effects of existing treatments, which can enhance patient mobility and quality of life. By prioritizing the development of breakthrough therapeutics, PolyCore Therapeutics seeks to address significant healthcare challenges while also aiming to reduce overall healthcare costs for patients suffering from neurological diseases.
Ultraflex Systems
Seed Round in 2016
Ultraflex Systems specializes in designing and engineering custom Range of Motion (ROM) braces that enhance movement and promote active living. With over 25 years of experience, the company collaborates closely with physicians, physical therapists, and specialists to deliver innovative orthopedic and neurological solutions. Ultraflex Systems distinguishes itself through a dedicated direct care team, which includes sales professionals and certified orthotists or fitters. This team oversees the entire process from the physician's referral to brace delivery and subsequent patient follow-up. The company’s custom-molded braces are crafted in its fabrication facilities to ensure optimal fit and effectiveness, ultimately improving joint and limb motion and supporting the musculoskeletal system for better patient outcomes.
Cagent Vascular
Seed Round in 2016
Cagent Vascular, LLC is a medical device company that specializes in developing innovative angioplasty balloons utilizing proprietary serration technology. Incorporated in 2014 and based in Wayne, Pennsylvania, the company has created the Serranator, a unique angioplasty device featuring serrated metal strips embedded in a semi-compliant balloon. This device is designed to treat atherosclerosis by effectively addressing blocked arteries, particularly in patients with peripheral artery disease and chronic limb-threatening ischemia. Cagent Vascular's technology aims to enhance the effectiveness of vessel dilatation procedures in cardiovascular interventions, providing healthcare providers with advanced tools to improve patient outcomes.
Arcadian Telepsychiatry Services
Seed Round in 2016
Arcadian Telepsychiatry Services, based in Fort Washington, Pennsylvania, specializes in providing psychiatric services through a telehealth platform. Established in 2012, the company connects psychiatrists and mental health providers with patients in both urban and remote locations. Its comprehensive offerings include on-demand emergency consultations for emergency departments and crisis centers, inpatient consultations, initial psychiatric evaluations, medication management, and scheduled clinic services for children, adolescents, and adults. Additionally, Arcadian provides training and education for hospital personnel, pre-admission psychiatric exams, and follow-up services. The company also facilitates video conferencing and internet access for hospitals, clinics, and public health departments, and offers behavioral health solutions for skilled nursing and assisted living facilities. By leveraging technology, Arcadian aims to enhance accessibility to mental health care, reduce travel times, and foster collaboration among providers, families, and patients.
Essential Medical
Seed Round in 2016
Essential Medical is a family owned & operated business that was started in 1985. We are a broad based supplier of home medical and health related products designed with the needs of the user in mind. Within this online website you will find many different product options to meet a variety of life styles and physical conditions. If you are a home medical equipment dealer and would like to be set up to order Essential products, please click on the Prospective Dealers tab. If you would like to purchase products for yourself, family member or friend, our fine products are available through your local medical equipment dealer or pharmacy. Please consult the yellow pages of your local telephone book under Hospital and Medical Equipment.
Instadiagnostics
Seed Round in 2016
Instadiagnostics Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing a point-of-care (POC) diagnostic platform. Founded in 2015, the platform aims to bring centralized laboratory testing directly to patients at their bedside, facilitating early diagnosis and treatment monitoring. This innovative approach allows patients to receive timely medical care in various settings, including primary care centers, community clinics, and emergency departments, without the need for additional trips to have blood drawn or enduring long wait times for results. By streamlining the diagnostic process, Instadiagnostics seeks to enhance patient care and satisfaction, reduce the frequency of medical visits, and ultimately lower overall healthcare costs.
Dynamis Skin Science
Seed Round in 2016
Dynamis Skin Science, Inc. is a Jenkintown, Pennsylvania-based company focused on developing and supplying innovative skin care products featuring its proprietary ingredient, Supplamine. Founded in 2006, the company offers a diverse range of products aimed at enhancing skin health and addressing anti-aging concerns. Its product portfolio includes treatments for the face, eyes, and hands, as well as moisturizers and cleansers designed to improve skin appearance and health. Dynamis Skin Science markets its offerings through authorized distributors, online platforms, and licensed skin-care professionals, ensuring accessibility to a broad customer base. The company operates as a subsidiary of Dynamis Therapeutics, Inc.
Life.io
Seed Round in 2016
Life.io is the world’s first web-based platform specifically designed to help people make better decisions every moment, to take care of themselves more, to engage more, to simply live more. Delivered through insurance companies or employers, it’s always on, sharing inspired ideas on how to live better today and every day after.
Kynectiv, Inc. is a company specializing in simulation-based products and technology platforms aimed at enhancing decision-making and training across various sectors, particularly healthcare. Founded in 2010 and headquartered in Chadds Ford, Pennsylvania, Kynectiv offers a comprehensive platform that enables organizations to develop assessment, education, and training programs. Its flagship products include CommSim, which facilitates remote role-playing interactions between coaches and learners, and Synapse DX, designed to help healthcare organizations better understand and influence audience decision-making experiences. Kynectiv focuses on delivering real-world engagement, which enhances training efficacy, increases retention, and provides valuable data insights for clients. The company rebranded from DecisionSim, Inc. in 2015 and operates as a subsidiary of US HealthConnect, Inc.
ROAR for Good LLC is a woman-led technology company based in Philadelphia, Pennsylvania, focused on enhancing personal safety through innovative solutions. Established in 2014, the company designs self-defense jewelry and mobile technology aimed at reducing assault incidents, particularly against women. Its flagship product, the AlwaysOn employee safety platform, caters specifically to the hotel industry, ensuring compliance with safety standards while promoting employee well-being. The platform operates on mission-critical networks, providing reliable protection even without Wi-Fi or power. Additionally, ROAR for Good offers self-defense education to empower women and improve workplace safety across various sectors, including hospitality and healthcare.
Life.io
Seed Round in 2015
Life.io is the world’s first web-based platform specifically designed to help people make better decisions every moment, to take care of themselves more, to engage more, to simply live more. Delivered through insurance companies or employers, it’s always on, sharing inspired ideas on how to live better today and every day after.
DecNut develops point-of-care technologies aimed at enhancing clinical decision-making across various healthcare settings. The company offers tools that integrate evidence-based clinical practice guidelines into the workflows of healthcare providers. By doing so, DecNut enables professionals to optimize resource utilization and improve patient care outcomes. Their solutions facilitate the aggregation, updating, dissemination, and evaluation of tailored clinical decision support, ultimately enhancing the overall quality of clinical judgment in diverse healthcare environments.
Halo Labs
Seed Round in 2015
Halo Labs is a life science instrumentation company based in Burlingame, California, specializing in the development of tools for biologics researchers. Formerly known as Optofluidics, the company focuses on high throughput biopharmaceutical quality control, utilizing advanced optics, image processing, and microfluidics technologies. Halo Labs' offerings include assessment of biologics-developability, formulation development, late-stage formulation, small molecule solubility, and AAV analytics. Founded in 2011, the company has gained recognition for its innovative scientific platform, which provides critical insights into the particles involved in research processes, thereby enhancing the stability and quality assessment of biological drugs.
ZSX Medical
Venture Round in 2015
ZSX Medical is a medical device development company based in Philadelphia, Pennsylvania, founded in 2009. The company specializes in creating bio-absorbable products for internal closure in minimally invasive surgeries. Their flagship product, Zip-stitch, is a surgical closure system designed to simplify and expedite difficult surgical closures, particularly for uterine closure during cesarean deliveries. By reducing operative time and potential complications such as infection and tissue adhesion, ZSX Medical aims to improve patient outcomes and lower healthcare costs for hospitals.
Yorn LLC is a real-time feedback and engagement platform based in Philadelphia, Pennsylvania, focused on enhancing the customer experience across various sectors, including healthcare, hospitality, and business. Founded in 2008, the company provides a platform that allows patients and consumers to share their experiences through smartphones, tablets, or laptops. This enables healthcare providers and payers to identify underlying issues and implement operational changes that improve patient satisfaction and compliance with care plans. Yorn captures authentic consumer feedback, offering organizations actionable insights to better understand and enhance their services.
Grand Round Table
Seed Round in 2015
Grand Round Table Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing clinical decision support tools for healthcare providers. Its flagship product, Grand Round Table, is an integrated system designed to enhance the diagnostic capabilities of doctors by leveraging a vast database of deidentified health records, case reports, and evidence-based medical literature. This technology extracts pertinent information from patients' charts and matches it with similar cases, allowing physicians to reference previous treatments and outcomes in comparable scenarios. By facilitating faster and more accurate treatment plans, Grand Round Table aims to improve patient care, reduce unnecessary medical tests and consultations, and ultimately contribute to cost savings for hospitals and clinics. Established in 2011, the company focuses on translating available medical knowledge into actionable insights to support healthcare professionals in making informed decisions for diagnostically challenging cases.
Atrin Pharmaceuticals
Pre Seed Round in 2015
Atrin Pharmaceuticals LLC is a biopharmaceutical company based in Doylestown, Pennsylvania, that focuses on the discovery and development of innovative cancer treatments. Founded in 2011, Atrin is dedicated to transforming cancer therapy through its advanced drug candidates, including ATRN-502, a p53 activator, and ATRN-507, a dual ligand designed to selectively target cancer cells. The company utilizes its proprietary high-throughput screening platform, Atrize, which enables the identification and evaluation of compounds that effectively inhibit cancer cell viability while sparing healthy cells. Atrin's approach centers on addressing cancers associated with synthetic lethality and deregulated DNA damage response, with the goal of providing effective and safe therapeutic options for patients.
TowerView Health
Seed Round in 2015
TowerView helps the 1 in 3 Americans with a chronic illness manage multiple medications. TowerView’s patients receive pre-filled medication trays that fit into a connected pillbox like a K-Cup into a Keurig coffee machine. Their pillbox can sense when patients forget a dose and automatically sends a text or phone reminder. Unlike other smart pillboxes, they send patients pre-filled medication trays sourced from a pharmacy so patients never have to fill their own pillbox and they work directly with nurses to target outreach for non-adherent patients. TowerView is rolling out with Independence Blue Cross in January 2015 and are in advanced discussions with numerous other health plans.
Prescribe Well
Seed Round in 2015
PrescribeWell, Inc. is a technology company based in Hatfield, Pennsylvania, that specializes in developing a platform-as-a-service (PaaS) designed for healthcare providers and integrated healthcare systems. The platform facilitates the tracking and analysis of behavioral modifications related to health issues such as obesity, smoking cessation, and stress management. By integrating seamlessly with existing electronic medical records (EMR) systems, PrescribeWell provides a physician-centric hub that enhances patient engagement and facilitates wellness regimens. The solution not only supports healthcare providers in managing ongoing patient communications but also optimizes billing processes, thereby improving overall healthcare delivery. Incorporated in 2012, PrescribeWell aims to support healthcare professionals in achieving better patient health outcomes through effective lifestyle modifications and disease prevention strategies.
Kynectiv
Seed Round in 2015
Kynectiv, Inc. is a company specializing in simulation-based products and technology platforms aimed at enhancing decision-making and training across various sectors, particularly healthcare. Founded in 2010 and headquartered in Chadds Ford, Pennsylvania, Kynectiv offers a comprehensive platform that enables organizations to develop assessment, education, and training programs. Its flagship products include CommSim, which facilitates remote role-playing interactions between coaches and learners, and Synapse DX, designed to help healthcare organizations better understand and influence audience decision-making experiences. Kynectiv focuses on delivering real-world engagement, which enhances training efficacy, increases retention, and provides valuable data insights for clients. The company rebranded from DecisionSim, Inc. in 2015 and operates as a subsidiary of US HealthConnect, Inc.
CloudMine
Series A in 2015
CloudMine is a developer of a mobile backend-as-a-service (mBaaS) platform focused on enhancing healthcare mobility and patient health. The platform offers object-based data storage, file storage modules, and capabilities for sending push notifications, facilitating effective communication with users. By operationalizing data through application development, analytics, and workflows, CloudMine enables healthcare and life science organizations to create secure, interoperable, and scalable applications more efficiently and at a reduced cost. The company's managed mobility solution also accelerates app development by 70% and eliminates the need for ongoing maintenance and management, providing a standardized mobility platform with IT-approved tools across various business units.
Prescription Advisory Systems & Technology
Debt Financing in 2015
Prescription Advisory Systems & Technology, Inc. is a company based in Jenkintown, Pennsylvania, that specializes in developing software solutions to enhance the management of chronic pain treatment and mitigate the risks associated with prescription drug abuse. Its flagship product, PASTRx, is a Software as a Service (SaaS) platform designed to assist healthcare providers in identifying patients who are suitable for controlled substance prescriptions while highlighting those who may need more complex care or additional safety measures. PASTRx integrates data from multiple sources, allowing for comprehensive patient risk assessments and facilitating the retrieval of prescription monitoring program reports. This user-friendly software promotes auditability and institutional oversight, ultimately contributing to safer prescribing practices and protecting patients, physicians, and healthcare institutions amidst increasing scrutiny regarding prescription medication use. Incorporated in 2013, the company has developed its software with the guidance of pain management practitioners and in collaboration with various states and research initiatives.
Essential Medical
Seed Round in 2014
Essential Medical is a family owned & operated business that was started in 1985. We are a broad based supplier of home medical and health related products designed with the needs of the user in mind. Within this online website you will find many different product options to meet a variety of life styles and physical conditions. If you are a home medical equipment dealer and would like to be set up to order Essential products, please click on the Prospective Dealers tab. If you would like to purchase products for yourself, family member or friend, our fine products are available through your local medical equipment dealer or pharmacy. Please consult the yellow pages of your local telephone book under Hospital and Medical Equipment.
InstaMed
Venture Round in 2014
InstaMed Communications, LLC, founded in 2004 and headquartered in Philadelphia, Pennsylvania, operates a healthcare payments network that connects providers, payers, and consumers through a unified cloud-based platform. The company offers several products, including InstaMed Online for Providers and InstaMed Online for Payers, both of which facilitate secure management of healthcare payment transactions with role-based security. Additionally, InstaMed Connect integrates healthcare payments into existing IT applications via APIs. By streamlining electronic transactions and consolidating payment processes, InstaMed aims to reduce the risks and complexities associated with multiple payment vendors, ultimately enhancing consumer satisfaction and enabling providers to collect payments more efficiently. As of 2019, InstaMed operates as a subsidiary of JPMorgan Chase Bank, National Association.
Yorn LLC is a real-time feedback and engagement platform based in Philadelphia, Pennsylvania, focused on enhancing the customer experience across various sectors, including healthcare, hospitality, and business. Founded in 2008, the company provides a platform that allows patients and consumers to share their experiences through smartphones, tablets, or laptops. This enables healthcare providers and payers to identify underlying issues and implement operational changes that improve patient satisfaction and compliance with care plans. Yorn captures authentic consumer feedback, offering organizations actionable insights to better understand and enhance their services.
Stabiliz Orthopaedics
Seed Round in 2014
Stabiliz Orthopaedics, LLC is a company based in Exton, Pennsylvania, that specializes in the development and distribution of orthopedic devices. Founded in 2009, the company focuses on creating innovative enhancements to orthopedic medical technologies that are FDA approved. Stabiliz Orthopaedics aims to improve clinical outcomes and reduce healthcare costs, addressing the challenges faced by healthcare systems. Through its commitment to advancing orthopedic care, the company seeks to provide effective solutions that enhance patient treatment and recovery.
Photosonix Medical
Seed Round in 2014
Photosonix Medical, headquartered in Ambler, Pennsylvania, specializes in the development of innovative skincare treatment devices. Their flagship product, CLENS™ (Coincident Light Energy and Non-focused UltraSound), synergistically combines light and ultrasound energy to effectively treat chronic bacterial infections known as biofilms, particularly targeting moderate to severe acne. The company aims to provide a convenient at-home solution for users, reducing the risk of permanent skin scarring. Their primary target prescribers are dermatologists and primary care physicians.
Advent Therapeutics
Seed Round in 2014
Advent Therapeutics, based in Lumberville, Pennsylvania, is dedicated to developing therapies for micro-orphan applications, specifically targeting serious unmet medical needs in neonatal and pediatric populations. The company focuses on legacy drugs designed to address disorders in newborns, particularly those requiring intensive care in hospital settings. By providing specialized prenatal, neonatal, and pediatric medications, Advent Therapeutics aims to enhance the care pediatricians and healthcare professionals can offer to fragile patients, thereby improving health outcomes for these vulnerable groups.
Vy Corporation
Seed Round in 2014
Vy Corporation is a software development company based in Wayne, Pennsylvania, specializing in shape detection and object analysis for the medical imaging market. The company offers a cloud-based image analysis and data collection service known as CytoSavvy.com, which utilizes its patented CellQuant™ search technology to identify clusters of cells in various types of biopsies. This service aids pathologists and medical researchers by enhancing their ability to analyze complex cell structures efficiently and reliably. Additionally, Vy Corporation provides VectorSavvy.com, a platform that allows users to access image analysis technology, upload images, and view results. The company also engages in the development of custom projects tailored to specific client needs within the medical imaging sector.
Cro Analytics
Seed Round in 2014
CRO Analytics, LLC is a company headquartered in New Hope, Pennsylvania, that specializes in providing data assessment tools and services for sponsors and contract research organizations. Established in 2011, the company offers a cloud-based clinical trial performance system known as Performer, which serves as a comprehensive trial assessment platform. This platform delivers in-trial alerts and insights into clinical research performance, enabling clinical research executives, functional area managers, and trial management teams to enhance research quality, efficiency, and cost-effectiveness. CRO Analytics' system is distinguished by its ability to collect, analyze, and report on performance metrics through a statistically validated process, offering benchmarking and key performance indicators essential for optimizing outsourced clinical research. The company's innovative approach allows for a detailed analysis based on various parameters such as service provider, sponsor, region, study type, and therapeutic area, providing valuable insights into clinical trial management activities.
HealthQx, established in 2012 and headquartered in King of Prussia, Pennsylvania, specializes in Value-based Payment (VBP) analytic software solutions for health plans and providers. Its flagship product, ClarityQx, empowers users to design, implement, and monitor the performance of alternative payment models such as episodic or bundled arrangements. The platform facilitates provider engagement and contract negotiation processes, aiming to enhance consumer care while reducing medical costs.
MemVu, Inc. is a provider of brain health training solutions aimed at individuals and families. Founded in 2008 and headquartered in Shaker Heights, Ohio, the company offers a patent-pending platform that allows users to personalize brain exercises using their own photos, which can be integrated into various brain games and activities. This innovative approach enhances engagement and facilitates socialization, particularly for individuals experiencing brain health issues. MemVu’s solutions are utilized by a range of professionals, including physicians, social workers, and psychologists, as well as by hospitals, rehabilitation centers, adult daycare facilities, and assisted living communities. These resources not only support patient care but also foster connections between patients and their families, encouraging involvement in the care process through personalized photo messages and interactive exercises.
NetMinder
Seed Round in 2014
NetMinder specializes in providing a network comparison tool designed for medical, dental, vision, and behavioral health plan provider networks. The company's platform features an intuitive interface that allows users to generate detailed reports and analyses swiftly, facilitating improved decision-making for payers, brokers, and consultants. By offering easily shareable reports and the capability to quickly incorporate new competitors, NetMinder enhances the efficiency of sales teams and recruiters. This objective and validated source of provider network data enables clients to make informed employee benefit decisions, ultimately leading to increased recruitment of providers, more closed deals, and improved client retention.
Grand Round Table
Seed Round in 2014
Grand Round Table Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing clinical decision support tools for healthcare providers. Its flagship product, Grand Round Table, is an integrated system designed to enhance the diagnostic capabilities of doctors by leveraging a vast database of deidentified health records, case reports, and evidence-based medical literature. This technology extracts pertinent information from patients' charts and matches it with similar cases, allowing physicians to reference previous treatments and outcomes in comparable scenarios. By facilitating faster and more accurate treatment plans, Grand Round Table aims to improve patient care, reduce unnecessary medical tests and consultations, and ultimately contribute to cost savings for hospitals and clinics. Established in 2011, the company focuses on translating available medical knowledge into actionable insights to support healthcare professionals in making informed decisions for diagnostically challenging cases.
Essential Medical
Seed Round in 2014
Essential Medical is a family owned & operated business that was started in 1985. We are a broad based supplier of home medical and health related products designed with the needs of the user in mind. Within this online website you will find many different product options to meet a variety of life styles and physical conditions. If you are a home medical equipment dealer and would like to be set up to order Essential products, please click on the Prospective Dealers tab. If you would like to purchase products for yourself, family member or friend, our fine products are available through your local medical equipment dealer or pharmacy. Please consult the yellow pages of your local telephone book under Hospital and Medical Equipment.
BioDetego
Seed Round in 2014
BioDetego is focused on advancing cancer diagnostics through its innovative platform, VASPfore, which develops a biomarker test aimed at optimizing cancer treatment protocols. This test assesses the metastatic risk in colorectal cancer patients, allowing for more informed decisions regarding chemotherapy. By accurately identifying high-risk patients who would benefit from treatment, BioDetego seeks to mitigate the unnecessary costs and adverse effects associated with treating low-risk patients. The company anticipates significant savings for payors, estimated at over $150 million annually, through reduced overall treatment expenses. BioDetego is led by David Zuzga, Ph.D., a research scientist with a background in cell and molecular biology, and Giovanni M. Pitari, M.D., Ph.D., a physician and research scientist specializing in Translational Oncology.
Halo Labs
Seed Round in 2014
Halo Labs is a life science instrumentation company based in Burlingame, California, specializing in the development of tools for biologics researchers. Formerly known as Optofluidics, the company focuses on high throughput biopharmaceutical quality control, utilizing advanced optics, image processing, and microfluidics technologies. Halo Labs' offerings include assessment of biologics-developability, formulation development, late-stage formulation, small molecule solubility, and AAV analytics. Founded in 2011, the company has gained recognition for its innovative scientific platform, which provides critical insights into the particles involved in research processes, thereby enhancing the stability and quality assessment of biological drugs.
OrthogenRx
Seed Round in 2013
OrthogenRx is a commercial-stage product development company focused on providing orthopedic medical devices for treating musculoskeletal conditions. The company specializes in developing knee joint pain injections that lubricate the joint and relieve mild to moderate knee pain for patients who have not responded well to conservative therapies or simple analgesics. OrthogenRx's business model involves securing exclusive supply and license agreements for products already available outside the U.S., aiming to obtain generic product approval within the U.S. This strategy leverages existing regulations for abbreviated regulatory approval, similar to that of generic drugs, with the potential to significantly reduce healthcare costs.
ZSX Medical
Series A in 2013
ZSX Medical is a medical device development company based in Philadelphia, Pennsylvania, founded in 2009. The company specializes in creating bio-absorbable products for internal closure in minimally invasive surgeries. Their flagship product, Zip-stitch, is a surgical closure system designed to simplify and expedite difficult surgical closures, particularly for uterine closure during cesarean deliveries. By reducing operative time and potential complications such as infection and tissue adhesion, ZSX Medical aims to improve patient outcomes and lower healthcare costs for hospitals.
Annovis Bio
Seed Round in 2012
Annovis Bio, Inc., established in 2008 and headquartered in Berwyn, Pennsylvania, is a clinical-stage drug development company specializing in therapies for neurodegenerative disorders. Its primary focus is on Alzheimer's disease (AD) and Parkinson's disease (PD). Annovis Bio has two main compounds in clinical trials: ANVS401, currently in Phase 2a trials for early-stage AD and PD, as well as other chronic neurodegenerative conditions; and ANVS301, in Phase I trials to enhance cognitive function in advanced stages of AD. Additionally, the company is developing ANVS405 to protect the brain following traumatic brain injury or stroke.
Stabiliz Orthopaedics
Seed Round in 2012
Stabiliz Orthopaedics, LLC is a company based in Exton, Pennsylvania, that specializes in the development and distribution of orthopedic devices. Founded in 2009, the company focuses on creating innovative enhancements to orthopedic medical technologies that are FDA approved. Stabiliz Orthopaedics aims to improve clinical outcomes and reduce healthcare costs, addressing the challenges faced by healthcare systems. Through its commitment to advancing orthopedic care, the company seeks to provide effective solutions that enhance patient treatment and recovery.
EyeIC
Venture Round in 2012
EyeIC, Inc. is a medical technology company based in Wayne, Pennsylvania, specializing in the development and commercialization of imaging technologies for healthcare applications. Founded in 2004, EyeIC focuses on providing innovative solutions for eye care professionals and clinics. One of its key products, MatchedFlicker, is designed to monitor the onset and progression of glaucoma by detecting changes in time series retinal photographs. The technology automates the alignment and registration of images taken at different times, generating a superimposed view that facilitates analysis. Additionally, EyeIC's platform includes built-in interpretation and reporting tools, streamlining documentation and claims submission while assisting clinicians in identifying various retinal conditions, including diabetic retinopathy and retinopathy of prematurity. Through its advancements, EyeIC aims to enhance clinical workflows and improve patient care in the field of ophthalmology.
Prezacor
Seed Round in 2012
Prezacor, Inc. specializes in the development and marketing of innovative pain management solutions. The company's primary product, the Energeze™ Patch, utilizes its proprietary Energezics™ technology to deliver low wavelength energy aimed at alleviating both acute and chronic pain. The patch features a unique broad-area surface electrode crafted from a specialized formula that absorbs and resonates with a variety of naturally occurring waveforms found in living tissue. This technology allows users to effectively manage pain and discomfort across different areas of the body without the use of medicine.
Essential Medical
Seed Round in 2011
Essential Medical is a family owned & operated business that was started in 1985. We are a broad based supplier of home medical and health related products designed with the needs of the user in mind. Within this online website you will find many different product options to meet a variety of life styles and physical conditions. If you are a home medical equipment dealer and would like to be set up to order Essential products, please click on the Prospective Dealers tab. If you would like to purchase products for yourself, family member or friend, our fine products are available through your local medical equipment dealer or pharmacy. Please consult the yellow pages of your local telephone book under Hospital and Medical Equipment.
Essential Medical
Seed Round in 2010
Essential Medical, Inc. is a medical device company based in Malvern, Pennsylvania, that specializes in the development and marketing of femoral artery vascular closure devices. Founded in 2010, the company focuses on sealing femoral punctures that occur after diagnostic and interventional cardiac catheterization procedures. Essential Medical has developed two key devices, including MANTA, which is designed to close large bore punctures ranging from 10 to 24 French following various vascular access procedures such as transcatheter aortic valve replacement, abdominal aortic aneurysm repair, and balloon aortic valvuloplasty. These closures are critical in the rapidly growing field of interventional cardiology, enabling physicians to address the need for efficient and complication-free closure solutions. As of October 2018, Essential Medical operates as a subsidiary of Teleflex Incorporated.
SkillSurvey
Seed Round in 2007
SkillSurvey Inc. is a provider of cloud-based reference checking and credentialing solutions designed to enhance hiring processes for employers. Founded in 2001 and based in Berwyn, Pennsylvania, the company offers several key products, including SkillSurvey Reference, which automates the reference checking process; Hire 360, an online assessment tool that predicts job performance; and SkillSurvey Credential OnDemand, which facilitates real-time online responses from applicants and references. Additionally, SkillSurvey Source helps organizations identify new candidates through referrals. The company serves a diverse range of sectors, including healthcare, higher education, staffing and recruiting, retail, and engineering. With a focus on leveraging data-driven methodologies, SkillSurvey has developed patented solutions that improve the efficiency and accuracy of talent assessments, ultimately aiding organizations in making informed hiring decisions.
Ceptaris Therapeutics
Series B in 2006
Ceptaris Therapeutics, Inc. is a privately held specialty pharmaceutical company focused on developing innovative treatments for rare cancers. The company is working on a proprietary gel formulation of mechlorethamine hydrochloride aimed at treating early-stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). If successful, this investigational drug would be the first topical mechlorethamine product available to alleviate the signs and symptoms associated with this condition. In addition to its primary focus on CTCL, Ceptaris is also advancing YT-1006, an NMDA antagonist designed for treating neuropathic pain while mitigating side effects through a unique stereochemistry approach.
Acuity Pharmaceuticals
Series B in 2004
Acuity Pharmaceuticals is a pharmaceutical company based in Philadelphia, Pennsylvania, that specializes in developing treatments for ophthalmic diseases, particularly age-related macular degeneration and diabetic retinopathy. Founded in 2007, the company focuses on innovative therapies, including its clinical compound Cand5, a small interfering RNA therapeutic designed to treat vision loss by targeting vascular endothelial growth factor. In June 2011, Acuity Pharmaceuticals was acquired by OPKO Health, further enhancing its capabilities in the field of eye care.
SFA Therapeutics, Inc. is a development-stage biopharmaceutical company based in Jenkintown, Pennsylvania, that specializes in the development of microbiome-derived metabolites as therapeutic agents for chronic inflammatory diseases and cancer. The company focuses on harnessing compounds discovered in the human microbiome to create innovative treatments aimed at addressing conditions such as cancer, liver diseases, and autoimmune disorders. Through its novel platform, SFA Therapeutics seeks to advance the understanding and application of microbiome science in the field of medicine, providing new options for medical professionals in the treatment of these challenging health issues.